INGREZZA SPRINKLE FDA approval date

The FDA approved INGREZZA SPRINKLE on 30 Apr 2024.

FDA approval date
30 Apr 2024

Drug identity has not yet been verified against registry records

Also recorded as VALBENAZINE TOSYLATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2024-04-30DayINGREZZA SPRINKLEFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA218390", "applicant_as_listed_by_fda": "NEUROCRINE", "brand_names": ["INGREZZA SPRINKLE"], "active_ingredients": ["VALBENAZINE TOSYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20240430", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026